A Glimpse Into The Expert Outlook On Bristol-Myers Squibb Through 4 Analysts
A Glimpse Into The Expert Outlook On Bristol-Myers Squibb Through 4 Analysts
通过4位分析师的专业观点来了解施贵宝的前景
Analysts' ratings for Bristol-Myers Squibb (NYSE:BMY) over the last quarter vary from bullish to bearish, as provided by 4 analysts.
过去季度对施贵宝（NYSE：BMY）的分析师评级从看好到看淡不等，由4位分析师提供。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他们最近评级的精简视图，显示了过去30天的不同情绪，并将其与前几个月进行比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $44.25, a high estimate of $48.00, and a low estimate of $41.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 8.76%.
分析师评估的12个月目标价格揭示了更多信息，其中包括平均目标为44.25美元，最高预估为48.00美元，最低预估为41.00美元。随着分析师将平均价格目标下调了8.76％，情绪出现了负面转变。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：更深入的了解
An in-depth analysis of recent analyst...
近期分析师行动...
登录免费看全文
登录/注册